A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT05123586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to assess the efficacy and safety of LY3361237 in participants with at least moderately active systemic lupus erythematosus (SLE). Study will last up to 34 weeks and may include up to 15 visits.
Study identification
- NCT ID
- NCT05123586
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 85 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2022 (Actual)
- Primary completion
- Dec 29, 2023 (Actual)
- Completion
- Dec 29, 2023 (Actual)
- Last update posted
- Jan 20, 2025
2022 – 2023
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Associates, P. C. | Mesa | Arizona | 85210 | — |
| Arizona Arthritis & Rheumatology Associates | Phoenix | Arizona | 85037 | — |
| Arizona Arthritis & Rheumatology Research - Sun City | Sun City | Arizona | 85351 | — |
| Newport Huntington Med Grp | Huntington Beach | California | 92648 | — |
| Desert Medical Advances | Rancho Mirage | California | 92270 | — |
| Clinical Research of West Florida, Inc. (Clearwater) | Clearwater | Florida | 33765 | — |
| Ezy Medical Research | Miami | Florida | 33175 | — |
| Clinical Research of West Florida | Tampa | Florida | 33606 | — |
| Atlanta Research Center for Rheumatology | Marietta | Georgia | 30060 | — |
| Qualmedica Research, LLC | Evansville | Indiana | 47715 | — |
| Tekton Research, Inc | Wichita | Kansas | 67218 | — |
| Clinvest Research LLC | Springfield | Missouri | 65807 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| University of North Carolina | Hillsborough | North Carolina | 27278 | — |
| Paramount Medical Research | Middleburg Heights | Ohio | 44130 | — |
| Tekton Research, Inc. | Moore | Oklahoma | 73160 | — |
| Tekton Research, Inc | Austin | Texas | 78745 | — |
| Rheumatology Center Of Houston | Houston | Texas | 77004 | — |
| Houston Rheumatology & Arthritis Specialists | Katy | Texas | 77494 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05123586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2025 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05123586 live on ClinicalTrials.gov.